Skip to playerSkip to main content
  • 18 hours ago
Serious allegations of illegality, favouritism and market manipulation have surfaced before Parliament's Public Accounts Committee, as it examines the State's acquisition of pharmaceuticals in Trinidad and Tobago.

The Committee claims unlawful requirements were imposed on drug importers for nearly a decade — potentially benefitting a single company.

Category

🗞
News
Transcript
00:00For eight years, illegal and unlawful requirements were allegedly imposed on pharmaceutical importers.
00:07That claim was made today by Chairman of the Public Accounts Committee, Jack Deo Singh,
00:12as the committee examined the state's acquisition and registration of pharmaceuticals.
00:17This rogue public servant who enacted an ultra-virus requirement for something as important as the importation of new drugs
00:33into Trinidad
00:34was allowed to continue unchecked and unabated for seven whole years, eight whole years,
00:45without anybody in the ministry realizing that these forms introduced requirements that had no basis in law.
00:54The director of the Food and Drugs Division, who assumed office in late 2025,
01:00told the committee complaints were raised upon his arrival.
01:03When I came into office, there were some complaints coming in that the application was a bit onerous.
01:09Some documents, persons, especially smaller importers, were saying that there were some documents
01:15that they could not have gotten for the registration of drugs.
01:18I started looking at the requirements for registration against the legislation,
01:23and I realized that there were documents that were being asked for
01:26that were not listed within the example that was given in the legislation.
01:34At one point, the meeting grew heated with the chairman pressing officials on where the directive originated.
01:41Unfortunately, I have not been able to find out that answer,
01:44as a result of which, in September, I would have asked for the form to be reverted to the form
01:51prior to 2017.
01:53But Singh challenged whether the changes effectively locked smaller companies out of the market,
01:58creating what he described as a manufactured monopoly.
02:02So, while that company, that one single company, has been allowed to register almost 90% of the registered pharmaceuticals,
02:16the small importers have found it impossible to do so
02:21because of the plainly illegal and unlawful requirements introduced by a rogue public servant.
02:32Evidence presented to the committee suggested that screening outcomes under one officer
02:38showed significantly higher approval rates for certain large importers compared to others.
02:44Have you seen a report prepared in which screening applications performed by Mr. Imtiaz Ali
02:58resulted in a 97.8 acceptance rate for Massey, GSK, Aventa, and Bryden,
03:10compared to a 66.9% acceptance rate for other companies?
03:17The committee said the marketplace was purposefully constricted to suit one company.
03:22The one company that this benefited the most is Aventa, isn't it true?
03:27Smith-Robertson morphed into Aventa.
03:31They've had most of the registrations here.
03:33Not most of. Mr. Ali, listen, I want to be very respectful to you, right?
03:39Thank you, sir.
03:54The committee also raised concerns about enforcement actions during Operation Windsor,
04:01noting that some major pharmacy chains were reportedly not targeted during raids for illegal drugs.
04:09How many Super Farm Outlets were raided?
04:12Chair, at the point in time, zero.
04:16Zero.
04:18How many Massey pharmacies were raided?
04:22Chair, at the point in time, it was zero.
04:26Where were the concentration of pharmacies which were raided?
04:32I know the answer, Mrs. Sibu.
04:35I'm asking you a question to which I know the answer.
04:39They're all in South Trinidad.
04:42Most of them were in rural Trinidad and Tobago.
04:45Meanwhile, NIPDEC's general manager was questioned about delayed payments to smaller pharmacies supplying drugs under the CDAP program.
04:53So, Chairman, there was a meeting that was held with NIPDEC and the Ministry of Health team from 2023 to
05:01a period early in 2025 that, in terms of the various allocations of payments, were dictated by the ministry.
05:09Who from the Ministry of Health was there?
05:13Representative NIPDEC and executive team of the Ministry of Health.
05:17Who from the Ministry of Health was the minister there?
05:20Yes.
05:21The Public Accounts Committee says it intends to invite the named public servants, as well as the former minister, to
05:28appear and provide further evidence.
05:31I'm Rishi Tawari Rupnaraim, TV6 News.
Comments